Darexaban
Alternative Names: Darexaban maleate; YM 150Latest Information Update: 05 Nov 2023
At a glance
- Originator Astellas Pharma
- Class Antithrombotics; Azepines; Benzamides; Phenyl ethers; Small molecules
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acute coronary syndromes; Stroke; Thromboembolism; Venous thromboembolism
Most Recent Events
- 28 Sep 2011 Discontinued - Phase-II for Acute coronary syndromes in Australia (PO)
- 28 Sep 2011 Discontinued - Phase-II for Acute coronary syndromes in Canada (PO)
- 28 Sep 2011 Discontinued - Phase-II for Acute coronary syndromes in European Union (PO)